Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Zhang, Yan; Xiao, Meng; Zhang, Shulan; Xia, Peng; Cao, Wei; Jiang, Wei; Chen, Huan; Ding, Xin; Zhao, Hua; Zhang, Hongmin; Wang, Chunyao; Zhao, Jing; Sun, Xuefeng; Tian, Ran; Wu, Wei; Wu, Dong; Ma, Jie; Chen, Yú; Zhang, Dong; Xie, Jing; Yan, Xiaowei; Zhou, Xiang; Liu, Zhengyin; Wang, Jinglan; Du, Bin; Qin, Yan; Gao, Peng; Qin, Xuzhen; Xu, Yingchun; Zhang, Wen; Li, Taisheng; Zhang, Fengchun; Zhao, Yongqiang; Li, Yongzhe; Zhang, Shuyang

doi:10.1056/nejmc2007575

Public

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Published in New England Journal of Medicine • Apr 8, 2020

Authors:

Yan Zhang

Meng Xiao

Shulan Zhang

Abstract

The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covid-19 who were also seen in the same intensive care unit. Coagulopathy and antiphospholipid antibodies were seen in all three patients.

Subject

Coagulopathy

Coronavirus disease 2019 (COVID-19)

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!